Researchers at St. Jude correlated NK cell genotype and phenotype at diagnosis with minimal residual disease (MRD) after induction chemotherapy in childhood acute lymphoblastic leukemia (ALL), with a
[Detail]
PROTAC technology is emerging as a novel therapeutic method to target diseases caused by the abnormal expression of a disease-causing proteins. PROTACs simultaneously bind a target protein and its E3-ubiquitin ligase, causing ubiquitination and degradation of the target protein. Studying protein-pro.....
[Detail]
Rapid Cloning of T Cell Receptors (TCRs) (SJ-16-0001)/ (Rapid cloning, expression, and functional characterization of paired αβ and γδ TCR chains from single cell analysis)St. Jude Reference #SJ-1
[Detail]
Executive Summary Plants are vulnerable to pathogen and insect attack. Typically, pathogen or insect attack elicits a defense response from the plant. Normally, plants choose between new growth and defending against insects or pathogens, and growth is slowed or stopped while the plant is defending .....
[Detail]
In addition to those mentioned above, the researchers are currently exploring other biological applications, such as controlled drug release, biomedical implants, artificial organs, and cell-based experimentation platforms.
[Detail]
| |< <- | [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] | -> >| |
